For the Quarter Ending June 2026
Ketoprofen Prices in APAC
- In China, the Ketoprofen Price Index rose by 14.551% quarter-over-quarter, driven by export demand and discipline.
- The average Ketoprofen price for the quarter was approximately USD 61666.67/MT on FOB Shanghai basis.
- Ketoprofen Spot Price stayed firm as intermediate aromatics rose, enabling producers to recover higher operating costs.
- Ketoprofen Production Cost Trend showed upward pressure from benzene and chlorine, slightly compressing downstream conversion margins.
- Ketoprofen Demand Outlook steady as formulators in India, Brazil and Germany continue restocking for seasonal production.
- Ketoprofen Price Forecast suggests modest firmness into autumn supported by export bookings and disciplined producer allocation.
- Ketoprofen Price Index movements reflected tighter coastal inventories and logistics disruptions, lengthening lead times, firming offers.
- Major GMP-compliant Chinese producers maintained steady operating rates while prioritising long-term contracts, reducing available prompt cargoes.
Why did the price of Ketoprofen change in June 2026 in APAC?
- Exporters disciplined allocations and steady operating rates further tightened spot availability, enabling producers to raise FOB offers.
- Upstream benzene and chlorine cost remained broadly stable, limiting cost-pull but earlier intermediate hikes elevated margin requirements.
- Increased enquiries from India and Brazil, plus Shanghai port congestion lengthened lead times, supporting firmer market sentiment.
India
- In India, the Ketoprofen Price Index rose by 0.91% quarter-over-quarter, supported by firmer intermediates, modestly.
- Ketoprofen Spot Price remained subdued as exporters released stock and domestic formulators delayed spot purchases.
Ketoprofen Prices in North America
- Ketoprofen Spot Price strengthened throughout Q2 2026 as pharmaceutical manufacturers replenished inventories ahead of summer demand cycles.
- Ketoprofen Production Cost Trend increased due to elevated costs of pharmaceutical intermediates, solvents, and regulatory compliance requirements.
- Ketoprofen Demand Outlook remained positive as analgesic and anti-inflammatory drug manufacturers maintained stable production schedules.
- Ketoprofen Price Forecast indicates stable-to-firm pricing in the near term, supported by healthy pharmaceutical consumption and moderate inventory levels.
- The Ketoprofen Price Index reflected bullish sentiment as buyers secured material through forward contracts amid concerns over import lead times.
- Major distributors reported adequate stock levels, although procurement activity increased toward the end of the quarter.
Why did the price of Ketoprofen change in June 2026 in North America?
- Strong procurement from pharmaceutical manufacturers increased demand for active pharmaceutical ingredients during June.
- Rising costs of intermediates, solvents, and logistics raised overall production and procurement expenses.
- Inventory replenishment ahead of seasonal analgesic demand supported firmer supplier quotations.
Ketoprofen Prices in Europe
- Ketoprofen Spot Price remained firm as pharmaceutical companies maintained regular procurement programs for pain-management products.
- Ketoprofen Production Cost Trend moved upward due to higher costs of chemical intermediates, energy, and transportation.
- Ketoprofen Demand Outlook remained constructive as healthcare and generic drug manufacturers sustained consistent production volumes.
- Ketoprofen Price Forecast suggests stable-to-firm movement amid healthy downstream demand and balanced inventories.
- The Ketoprofen Price Index reflected positive market sentiment as distributors replenished stocks ahead of anticipated summer consumption.
- Market participants monitored Asian API shipments closely, as Europe remained partly dependent on imported pharmaceutical raw materials.
Why did the price of Ketoprofen change in June 2026 in Europe?
- Stable pharmaceutical demand from pain-relief and anti-inflammatory drug manufacturers supported procurement activity.
- Higher feedstock, energy, and transportation costs increased production and import expenses.
- Inventory restocking by distributors and generic drug manufacturers strengthened spot market sentiment.
For the Quarter Ending March 2026
Ketoprofen Prices in APAC
- In China, the Ketoprofen Price Index fell by 1.4% quarter-over-quarter, reflecting marginally weaker export demand.
- The average Ketoprofen price for the quarter was approximately USD 53833.33/MT, reflecting FOB Shanghai averages.
- Export-driven firmness elevated the Ketoprofen Spot Price as western buyers targeted certified GMP Shanghai cargoes.
- Producers cited constrained Ketoprofen Production Cost Trend due to higher benzene-linked intermediate and chlorine costs.
- Short-term Ketoprofen Price Forecast shows modest upside driven by export restocking and environmental compliance downtime.
- Domestic hospitals provided price floor but the Ketoprofen Demand Outlook remained neutral to soft amid capped procurement.
- Inventory accumulation ahead of Lunar New Year pressured offers in the Ketoprofen Price Index trajectory.
- Major Zhejiang and Shandong plants kept runs, supporting availability as smaller workshops faced compliance-driven outages.
Why did the price of Ketoprofen change in March 2026 in APAC?
- Feedstock tightening and benzene-linked intermediate cost increases elevated manufacturer conversion costs, tightening finished-product availability material
- Strong export enquiries from India, Brazil, Germany absorbed cargoes, intensifying upward pressure on FOB offers.
- Environmental inspections paused small halogenation units, reducing secondary supply while ports remained operational without major delays.
Ketoprofen Prices in North America
- In the United States, the Ketoprofen Price Index showed a firm-to-rising trend over the quarter, supported by steady import demand and tighter global supply conditions.
- The average Ketoprofen price for the quarter was assessed at elevated levels, reflecting CIF U.S. port averages influenced by higher import costs.
- Import reliance kept the Ketoprofen Spot Price sensitive to overseas supplier pricing, with March witnessing firmer offers from Asian exporters.
- The Ketoprofen Production Cost Trend in exporting regions, particularly rising benzene-linked intermediates and chlorine costs, translated into higher landed costs for U.S. buyers.
- The Ketoprofen Price Forecast indicates continued firmness, driven by stable pharmaceutical demand and sustained import dependency.
- The Ketoprofen Demand Outlook remained steady, supported by consistent consumption from the healthcare and pharmaceutical formulation sectors.
- Import flows from China and Europe ensured availability, though longer lead times and freight costs limited aggressive stocking.
- Distributors maintained cautious inventories, with selective restocking observed toward the end of the quarter as prices began to firm.
Why did the price of Ketoprofen change in March 2026 in the USA?
- Rising FOB prices in Asia, driven by higher feedstock and compliance costs, increased import prices into the U.S.
- Restocking activity by pharmaceutical distributors tightened spot availability, supporting a price uptick.
- Elevated freight rates and logistical costs raised overall landed costs, reducing flexibility for buyers and firming market sentiment.
Ketoprofen Prices in Europe
- In Germany, the Ketoprofen Price Index followed a stable-to-firm trajectory during the quarter, influenced by import dependency and steady downstream demand.
- The average Ketoprofen price reflected imports benchmarks, with gradual strengthening observed through March.
- The Ketoprofen Spot Price increased slightly toward the end of the quarter as import offers firmed and regional inventories tightened.
- Upstream Ketoprofen Production Cost Trend in exporting countries, especially higher raw material and energy costs, contributed to increased procurement prices for German buyers.
- The Ketoprofen Price Forecast suggests a firm outlook, supported by stable pharmaceutical demand and persistent cost pressures.
- The Ketoprofen Demand Outlook remained consistent, with pharmaceutical manufacturers maintaining routine procurement cycles.
- Imports from China and other Asian suppliers dominated supply, while limited domestic production reinforced reliance on external markets.
- Inventory levels remained balanced, though restocking ahead of spring demand cycles contributed to mild upward pressure on the Ketoprofen Price Index.
Why did the price of Ketoprofen change in March 2026 in Germany?
- Increased import costs due to higher Asian FOB prices and rising energy-linked production expenses supported price gains.
- Seasonal restocking by pharmaceutical companies reduced available inventories, tightening spot supply.
- Higher inland transportation and regulatory compliance costs across Europe increased effective procurement costs, reinforcing firmer pricing trends
For the Quarter Ending December 2025
Ketoprofen Prices in APAC
- In China, the Ketoprofen Price Index fell by 2.21% quarter-over-quarter, driven by restored operating rates.
- The average Ketoprofen price for the quarter was approximately USD 54600.00/MT, reflecting balanced supply and subdued buying.
- Ketoprofen Spot Price remained muted as coastal inventories stayed adequate and exporters normalized front-loaded shipments.
- Ketoprofen Price Forecast indicates modest near-term softness given comfortable finished-goods stocks and restrained hospital procurement.
- Ketoprofen Production Cost Trend softened as benzoyl chloride and 3-bromacetophenone feedstock prices eased modestly recently.
- Ketoprofen Demand Outlook stayed steady with hospital tender awards limiting spot buying and delaying replenishment.
- The Ketoprofen Price Index reflected seasonal maintenance completions, easing costs while prompting cautious seller adjustments.
- Logistics volatility and container freight premiums supported marginal pricing upside despite ample supply, keeping spot activity.
Why did the price of Ketoprofen change in December 2025 in APAC?
- Restored full operating rates increased finished-goods availability, easing seller urgency and pressuring offers downward modestly.
- Softer feedstock prices reduced conversion costs, allowing producers to trim FOB quotations and preserve margins.
- Muted hospital procurement after national VBP awards curtailed incremental spot purchases and normalized export orders.
Ketoprofen Prices in USA
- In the United States, the Ketoprofen Price Index edged slightly lower quarter-over-quarter, influenced by stable manufacturing output and moderate inventory levels.
- Ketoprofen Spot Price remained subdued as distributors maintained ample stock and hospital tender activity slowed.
- The Ketoprofen Price Forecast suggests near-term steadiness, with minor downside risk due to balanced supply and cautious procurement.
- Production Cost Trend showed slight relief as feedstock costs for benzoyl chloride and 3-bromacetophenone softened.
- Demand Outlook stayed stable, supported by consistent hospital and retail orders, though spot market buying remained selective.
- Reasons for December 2025 price movements in the USA:
- Consistent operating rates ensured steady output, maintaining inventory levels and preventing sharp price increases.
- Marginally lower feedstock costs allowed producers to adjust quotations without eroding margins.
- Slower hospital procurement and a lack of emergency spot buying kept short-term demand muted.
Ketoprofen Prices in Europe
- In Europe, the Ketoprofen Price Index recorded minor declines quarter-over-quarter, reflecting normalized plant operations and sufficient stock availability.
- Spot Prices were restrained as distributors held regular inventories and hospital tenders concluded for the period.
- Price Forecast indicates stable conditions, with potential slight softening if feedstock prices continue to ease.
- Production Costs were under modest pressure due to recent declines in key raw material prices.
- Demand Outlook remained steady, with hospital procurement schedules and tender awards limiting aggressive market buying.
- Logistics fluctuations, including container shipping rates, contributed to minor pricing adjustments but did not trigger sharp swings.
- Reasons for December 2025 price movements in Europe:
- Restored production rates and adequate finished-goods stock reduced the need for urgent sales, keeping pricing contained.
- Softer feedstock prices allowed manufacturers to maintain margins while moderating offers.
- Limited spot demand following tender closures restrained incremental purchases and stabilized the market.
For the Quarter Ending September 2025
APAC
- In China, the Ketoprofen Price Index fell by 5.37% quarter-over-quarter, reflecting oversupply and weak demand.
- The average Ketoprofen price for the quarter was approximately USD 55833.33/MT, reflecting inventory adjustments observed.
- Ketoprofen Spot Price weakened as distributors discounted stock, elevating pressure on the regional Price Index.
- Ketoprofen Price Forecast shows stabilization, then gradual recovery supported by maintenance-related supply tightening and restocking.
- Ketoprofen Production Cost Trend rose due to higher freight and feedstock, supporting supplier pricing discipline.
- Ketoprofen Demand Outlook remained weak as pharmaceutical buyers delayed procurement, exacerbating inventories and price pressure.
- Punitive export tariffs reduced outbound flows, increasing domestic competition and depressing the Ketoprofen Price Index.
- Spot market volatility reflected seasonal restocking, logistics bottlenecks, and selective destocking, shaping Ketoprofen Price Forecast.
Europe
- In Europe, the Ketoprofen Price Index was largely stable, with slight upward bias due to better-controlled inventories and moderate demand growth.
- Average price remained relatively flat to modestly increasing, supported by steady demand for topical gels/patches and compliance with stricter regulatory / sustainability standards.
- Marginal upward movement in the quarter, driven by periodic supply constraints of API, logistics shifts, and competitive pressure from Asian producers limiting excessive price rises.
- Rising, as pharmaceutical manufacturers incurred higher costs from regulatory compliance (e.g., environmental/GMP standards), feedstock and logistic burdens — this underpinned pricing discipline.
- Moderate growth, owing to aging populations, increasing use of topical NSAIDs, and self-medication trends. But growth is constrained by mature market saturation and competition.
- European suppliers face competition from Asian (China/India) producers, which exerts downward pressure on potential higher price rises; however, better inventory management has prevented oversupply.
North America
- In North America, the Ketoprofen Price Index saw a modest increase quarter-over-quarter, reflecting mature market demand and slightly tighter supply conditions.
- The average Ketoprofen price for the quarter was slightly above previous levels, driven by premium branded formulations and higher demand for topical/patch formats.
- Ketoprofen Spot Price strengthened as distributors and manufacturers capitalised on steady demand for non-opioid analgesics and topical/patch formats growing ~15% annually.
- Production Cost Trend in North America rose due to higher freight, regulatory compliance costs and feedstock costs — this supported supplier pricing discipline.
- Demand Outlook remained stable to positive: due to increasing musculoskeletal and arthritic conditions in aging populations, and preference for non-invasive topical solutions.
- While domestic manufacturing exists, reliance on imported API and global supply chain bottlenecks created some upward pressure on pricing.
- Spot market volatility was moderate, shaped by seasonal demand (e.g., winter musculoskeletal conditions), logistics cost increases, and restocking behaviours among distributors.
